Selling Prolastin sucks. It is a rare genetic disorder with several companies all vying for the same patients, all selling very similar products. Each company that enters this market believes that there is a large cache of undiagnosed patients that they will sucessfully uncover. Each company then fails in this regard.
It is a rare disease - but it the best alpha1 on the market.. And the market leader. Just a tuff market to sell in.
Nope, Prolastin is the most used but is NOT the best. There is one better for Alpha1 antitrypsin deficiency than Prolastin. Glad I switched.
what makes one better or 'the best'? its used to replace a missing protein-they all do the same thing
They all do the same thing. Three are exactly the same and one is basically the same thing in liquid form. Prolastin was first to market and pays off the organizations the most, so they are the current market leader.
